Effect of narrow band ultraviolet B on survivin in psoriatic skin lesions

European Journal of Dermatology

Volumn 21, Issue 6, 2011, Pages 866-869

  Nagui, Noha Abdel Rehim ^a   Abdel Hay, Rania Mounir ^a   Rashed, Laila Ahmed ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Apoptosis; Phototherapy; Psoriasis; Survivin

Indexed keywords

SURVIVIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NARROW BAND ULTRAVIOLET B RADIATION; OUTCOME ASSESSMENT; PHOTOTHERAPY; PROTEIN DETERMINATION; PSORIASIS; RADIATION RESPONSE; SCORING SYSTEM; SKIN BIOPSY; THERAPY EFFECT; TREATMENT DURATION; ULTRAVIOLET B RADIATION;

ADOLESCENT; ADULT; APOPTOSIS; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MIDDLE AGED; PSORIASIS; ULTRAVIOLET THERAPY; YOUNG ADULT;

EID: 84855987734     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2011.1496     Document Type: Article

References (16)

1. Van de Kerkhof PCM. Textbook of psoriasis. Oxford: Blackwell Publishing Ltd, 2003, 83-109.
2. Hussein MR, Al-Badaiwy ZH, Guirguis MN. Analysis of p53 and bcl-2 protein expression in the non-tumorigenic, pretumorigenic, and tumorigenic keratinocytic hyperproliferative lesions. J Cutan Pathol 2004; 31: 643-51.
3. Altieri DC, Marchisio PC. Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Invest 1999; 79: 1327-33.
4. Fukuda S, Pelus LM, Survivin LM. a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther 2006; 5: 1087-98.
5. D'Errico M, Lemma T, Calcagnile A, Proietti De Santis L, Dogliotti E. Cell type and DNA damage specific response of human skin cells to environmental agents. Mutat Res 2007; 614: 37-47.
6. Runger TM, Vergilis I, Sarkar P, Depinho RA, Sharpless NE. How disruption of cell cycle regulating genes might predispose to suninduced skin cancer. Cell Cycle 2005; 4: 643-645.
7. Rácz E, Prens EP, Kurek D, et al. Effective Treatment of psoriasis with Narrow-Band UVB Phototherapy Is Linked to Suppression of the IFN and Th17 Pathways. J Invest Dermatol 2011.[Epub ahead of print].
8. Dallaglio K, Palazzo E, Marconi A, et al. Endogenous survivin modulates survival and proliferation in UVB-treated human keratinocytes. Exp Dermatol 2009; 18: 464-71.
9. Kocak M, Bozdogan O, Erkek E, Atasoy P, Birol A. Examination of Bcl-2 Bcl-X and bax protein expression in psoriasis. Int J Dermatol 2003; 42: 789-93.
10. Bowen AR, Hanks AN, Murphy KJ, Florell SR, Grossman D. Proliferation, apoptosis, and survivin expression in keratinocytic neoplasms and hyperplasias. Am J Dermatopathol 2004; 26: 177-81.
11. Markham T, Mathews C, Rogers S, et al. Downregulation of the inhibitor of apoptosis protein survivin in keratinocytes and endothelial cells in psoriasis skin following infliximab therapy. Br J Dermatol 2006; 155: 1191-6.
12. Abdou AG, Hanout HM. Evaluation of survivin and NFkappaB in psoriasis, an immunohistochemical study. J Cutan Pathol 2008; 35: 445-51.
13. Bongiovanni L, Müller EJ, Salda LD. Survivin in skin pathologies. Exp Dermatol 2011; 20: 457-63.
14. Dohi T, Okada K, Xia F, et al. An IAP-IAP complex inhibits apoptosis. J Biol Chem 2004; 279: 34087-34090.
15. Takasawa R, Nakamura H, Mori T, Tanuma S. Differential apoptotic pathways in human keratinocyte HaCaT cells exposed to UVB and UVC. Apoptosis 2005; 10: 1121-1130.
16. Qin LY, Xing WB, Ye WJ. Effect of combined therapy with Chinese drug and narrow broad ultraviolet B on Bcl-2, caspase-3 and survivin in skin lesion with psoriasis vulgaris. Zhongguo Zhong Xi Yi Jie He Za Zhi 2010; 30: 706-9.